The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis
Open accessAbstract
There is growing evidence of activated microglia and inflammatory processes in the cerebral cortex in amyotrophic lateral sclerosis (ALS). Activated microglia is characterized by increased expression of the 18 kDa translocator protein (TSPO) in the brain and may be a useful biomarker of inflammation. In this study, we evaluated neuroinflammation in ALS patients using a radioligand of TSPO, (18)F-DPA-714. Ten patients with probable or definite ALS (all right-handed, without dementia, and untreated by riluzole or other medication that might bias the binding on the TSPO), were enrolled prospectively and eight healthy controls matched for age underwent a PET study. Comparison of the distribution volume ratios between both groups were performed using a Mann-Whitney's test. Significant increase of distribution of volume ratios values corresponding to microglial activation was found in the ALS sample in primary motor, supplementary motor and temporal cortex (p = 0.009, p = 0.001 and p = 0.004, respectively). These results suggested that the cortical uptake of (18)F-DPA-714 was increased in ALS patients during the "time of diagnosis" phase of the disease. This finding might improve our understanding of the pathophysiology of ALS and might be a surrogate marker of efficacy of treatment on microglial activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“presumably due to increased CNS microglia or their activation, as suggested by positron emission tomography (PET) imaging using radiotracers specific for activated microglia [423,424].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [423]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Pochet, P. (2006) · Griffith Research Online · Cited by 1,550
Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., et al. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.005 · Cited by 1,389
UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Prevalence and patterns of cognitive impairment in sporadic ALS
Ringholz, G. M., Appel, S. H., Bradshaw, M. R., Cooke, N., Mosnik, D. M., & Schulz, P. E. (2005) · Neurology · doi:10.1212/01.wnl.0000172911.39167.b6 · Cited by 843
Research works printed but not linked: 1
- I Bertrand, 1925, La sclérose latérale amyotrophique (Anatomie pathologique), RevNeurol, 1, 779
Cited by
Sorted by citations
Items 101–200 of 256
Rodríguez-Chinchilla, T., Quiroga‐Varela, A., Molinet-Dronda, F., Belloso-Iguerategui, A., Merino-Galán, L., Jiménez‐Urbieta, H., Gago, B., & Rodríguez‐Oroz, M. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04772-4 · Cited by 35
Ruiz‐Ruiz, C., García‐Magro, N., Negredo, P., Avendaño, C., Bhattacharya, A., Ceusters, M., & Garcı́a, A. G. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045732 · Cited by 35
Weehaeghe, D. V., Babu, S., Vocht, J. D., Zürcher, N. R., Chew, S., Tseng, C.-E. J., Loggia, M. L., Koole, M. J. B., Rezaei, A., Schramm, G., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.241059 · Cited by 34
Microglial TREM2 in amyotrophic lateral sclerosis
Xie, M., Zhao, S., Bosco, D. B., Nguyen, A. T., & Wu, L. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22864 · Cited by 35
Foucault-Fruchard, L., Doméné, A., Page, G., Windsor, M., Emond, P., Rodrigues, N., Dollé, F., Damont, A., Buron, F., Routier, S., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.019 · Cited by 32
Trageser, K. J., Smith, C., Herman, F. J., Ono, K., & Pasinetti, G. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01298 · Cited by 31
Ory, D., Postnov, A. A., Koole, M. J. B., Celen, S., de Laat, B., Verbruggen, A., Laere, K. V., Bormans, G. M., & Casteels, C. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3172-9 · Cited by 32
Abnormal Functional Connectivity Density in Amyotrophic Lateral Sclerosis
Li, W., Zhang, J., Zhou, C., Hou, W., Hu, J., Feng, H., & Zheng, X. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00215 · Cited by 31
Liu, E., Karpf, L., & Bohl, D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.767041 · Cited by 32
Hommet, C., Mondon, K., Camus, V., Ribeiro, M. J., Beaufils, É., Arlicot, N., Corcia, P., Paccalin, M., Minier, F., Gosselin, T., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000354363 · Cited by 36
Self-citationEfficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis
Goldshtein, H., Muhire, A., Légaré, V. P., Pushett, A., Rotkopf, R., Shefner, J. M., Peterson, R. T., Armstrong, G. A. B., & Russek‐Blum, N. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51174 · Cited by 30
TSPO as a target for glioblastoma therapeutics
Werry, E. L., Barron, M. L., & Kassiou, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150015 · Cited by 31
Self-citationMicroglia in ALS: Insights into Mechanisms and Therapeutic Potential
Bond, S., Saxena, S., & Sierra-Delgado, J. A. (2025) · Cells · doi:10.3390/cells14060421 · Cited by 32
Erber, A. C., Çetin, H., Berry, D., & Schernhammer, E. S. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1702549 · Cited by 28
Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
Calafatti, M., Cocozza, G., Limatola, C., & Garofalo, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223096 · Cited by 29
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
Marchi, F. D., Tondo, G., Corrado, L., Menegon, F., Aprile, D., Anselmi, M., D’Alfonso, S., Comi, C., & Mazzini, L. (2023) · Genes · doi:10.3390/genes14081658 · Cited by 31
Variational Segmentation of Vector-Valued Images With Gradient Vector Flow
Jaouen, V., González, P., Stute, S., Guilloteau, D., Chalon, S., Buvat, I., & Tauber, C. (2014) · IEEE Transactions on Image Processing · doi:10.1109/tip.2014.2353854 · Cited by 27
Self-citationKitagawa, Y., Nakaso, K., Horikoshi, Y., Morimoto, M., Omotani, T., Otsuki, A., Inagaki, Y., Sato, H., & Matsura, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-44006-8 · Cited by 28
Liu, C. H., Abrams, N., Carrick, D. M., Chander, P., Dwyer, J. T., Hamlet, M. R. J., Kindzelski, A., PrabhuDas, M., Tsai, S., Vedamony, M. M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201902024 · Cited by 26
Biesmans, S., Acton, P. D., Cotto, C., Langlois, X., Donck, L. V., Bouwknecht, J. A., Aelvoet, S., Hellings, N., Meert, T. F., & Nuydens, R. (2015) · Glia · doi:10.1002/glia.22804 · Cited by 26
Düzel, E., Costagli, M., Donatelli, G., Speck, O., & Cosottini, M. (2021) · European Radiology Experimental · doi:10.1186/s41747-021-00221-5 · Cited by 29
Biological evaluation of synthetic chalcone and flavone derivatives as anti-inflammatory agents
Mateeva, N. N., Gangapuram, M., MAZZIO, E. A., Eyunni, S., Soliman, K. F. A., & Redda, K. K. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1214-7 · Cited by 25
Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A. K., Jacobs, A. H., & IMBI Project (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.02.004 · Cited by 25
Glia as antigen-presenting cells in the central nervous system
Sutter, P. A., & Crocker, S. J. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102646 · Cited by 24
Rodríguez‐Cueto, C., Gómez‐Almería, M., García‐Toscano, L., Romero, J., Hillard, C. J., de Lago, E., & Fernández‐Ruíz, J. (2021) · Brain Pathology · doi:10.1111/bpa.12972 · Cited by 22
Calcium in the pathomechanism of amyotrophic lateral sclerosis – Taking center stage?
Patai, R., Nógrádi, B., Engelhardt, J. I., & Siklós, L. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.089 · Cited by 24
Prado, L. D. G. R., Rocha, N. P., de Souza, L. C., Bicalho, I. C. S., Gómez, R. S., Vidigal-Lopes, M., Braz, N. F. T., Vieira, É. L. M., & Teixeira, A. L. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.08.033 · Cited by 22
Contributions of Drug Transporters to Blood-Brain Barriers
Liu, L., & Liu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_9 · Cited by 21
Fournier, C. N., Houser, M. C., Tansey, M. G., Glass, J. D., & Hertzberg, V. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.007 · Cited by 21
Cipollina, G., Serej, A. D., Nolfi, G. D., Gazzano, A., Marsala, A., Spatafora, M. G., & Peviani, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217923 · Cited by 20
Emerging contributions of formyl peptide receptors to neurodegenerative diseases
Busch, L., Vieten, S., Brödel, S., Endres, K., & Bufe, B. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0258 · Cited by 21
Brainstem glucose hypermetabolism in ALS/FTD and shorten survival: a 18 F-FDG PET/MR study
Zanovello, M., Sorarú, G., Campi, C., Anglani, M., Spimpolo, A., Berti, S., Bussè, C., Mozzetta, S., Cagnin, A., & Cecchin, D. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262232 · Cited by 28
Kaneko, K., Irie, S., Mawatari, A., Igesaka, A., Hu, D., Nakaoka, T., Hayashinaka, E., Wada, Y., Doi, H., Watanabe, Y., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05719-7 · Cited by 20
PET and MR imaging of neuroinflammation in hepatic encephalopathy
Su, Y. Y., Yang, G. F., Lu, G., Wu, S., & Zhang, L. J. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9633-1 · Cited by 20
Further development of biomarkers in amyotrophic lateral sclerosis
Blasco, H., Vourc’h, P., Pradat, P., Gordon, P. H., Andres, C. R., & Corcia, P. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1199277 · Cited by 21
Self-citationSako, W., Izumi, Y., Abe, T., Haji, S., Murakami, N., Osaki, Y., Matsumoto, Y., Harada, M., & Kaji, R. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05107-3 · Cited by 19
Neuropathological profile of long‐duration amyotrophic lateral sclerosis in military Veterans
Spencer, K. R., Foster, Z. W., Rauf, N. A., Guilderson, L., Collins, D., Averill, J. G., Walker, S. E., Robey, I., Cherry, J. D., Alvarez, V. E., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12876 · Cited by 20
Bertin, É., Martínez, A., Fayoux, A., Carvalho, K., Carracedo, S., Fernagut, P., Koch‐Nolte, F., Blum, D. L., Bertrand, S. S., & Boué‐Grabot, É. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04461-5 · Cited by 19
Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders
Donatelli, G., Ceravolo, R., Frosini, D., Tosetti, M., Bonuccelli, U., & Cosottini, M. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0841-7 · Cited by 17
Trageser, K. J., Yang, E., Smith, C., Iban‐Arias, R., Oguchi, T., Sebastian-Valverde, M., Iqbal, U. H., Wu, H. D., Estill, M. S., Rahim, M. A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03315-w · Cited by 19
Radiotracers for Imaging of Inflammatory Biomarkers TSPO and COX-2 in the Brain and in the Periphery
Uzuegbunam, B. C., Rummel, C. D., Librizzi, D., Culmsee, C., & Yousefi, B. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417419 · Cited by 20
Thomas, C., Vercouillie, J., Doméné, A., Tauber, C., Kassiou, M., Guilloteau, D., Destrieux, C., Sérrière, S., & Chalon, S. (2016) · Molecular Imaging · doi:10.1177/1536012116639189 · Cited by 18
Self-citationImaging neuroinflammation in Alzheimer’s and other dementias: recent advances and future directions
Brooks, D. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.049 · Cited by 17
Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis
Wong, J. K., Roselle, A. K., Shue, T. M., Shimshak, S. J. E., Beaty, J. M., Celestin, N., Gao, I., Griffin, R., Cudkowicz, M., & Sadiq, S. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac207 · Cited by 17
Médran‐Navarrete, V., Bernards, N., Kühnast, B., Damont, A., Pottier, G., Peyronneau, M., Kassiou, M., Marguet, F., Puech, F., Boisgard, R., et al. (2014) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3199 · Cited by 20
Self-citationTang, D., Fujinaga, M., Hatori, A., Zhang, Y., Yamasaki, T., Xie, L., Mori, W., Kumata, K., Liu, J., Manning, H. C., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.076 · Cited by 17
Reyes‐Leiva, D., Dols‐Icardo, O., Sirisi, S., Cortés‐Vicente, E., Turón‐Sans, J., de Luna, N., Blesa, R., Belbin, O., Montal, V., Alcolea, D. A., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.750543 · Cited by 18
Efficient tritiation of the translocator protein (18 kDa) selective ligand DPA‐714
Damont, A., Garcia‐Argote, S., Buisson, D., Rousseau, B., & Dollé, F. (2015) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3252 · Cited by 17
Kaiserová, M., Grambalova, Z., Otruba, P., Stejskal, D., Vranová, H. P., Mareš, J., Menšíková, K., & Kaňovský, P. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12735 · Cited by 16
Foss, C. A., Liu, L., Mease, R. C., Wang, H., Pasricha, P. J., & Pomper, M. G. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.189571 · Cited by 16
Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO)
Banister, S. D., Beinat, C., Wilkinson, S. M., Shen, B., Bartoli, C., Selleri, S., Pozzo, E. D., Martini, C., Chin, F. T., & Kassiou, M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.02.004 · Cited by 16
Self-citationWerry, E. L., King, V. A., Barron, M. L., Banister, S. D., Sokias, R., & Kassiou, M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.09.026 · Cited by 16
Self-citationDiagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter
de Carvalho, M. A., & Swash, M. (2023) · Clinical Neurophysiology Practice · doi:10.1016/j.cnp.2023.12.003 · Cited by 15
Little Helpers or Mean Rogue—Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis
Cihankaya, H., Theiß, C., & Matschke, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030993 · Cited by 16
Auvity, S., Goutal, S., Thezé, B., Chaves, C., Hosten, B., Kühnast, B., Saba, W., Boisgard, R., Buvat, I., Cisternino, S., et al. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.037 · Cited by 15
Cagalinec, M., Mohd, A., Borecká, S., Bultynck, G., Choubey, V., Yanovsky‐Dagan, S., Ezer, S., Gašperíková, D., Harel, T., Jurkovičová, D., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119954 · Cited by 15
Dysbiosis and Neurodegeneration in ALS: Unraveling the Gut–Brain Axis
Sharma, V. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08870-0 · Cited by 14
Tuddenham, J. F., Fujita, M., Lee, E., Nimmagadda, N., Khairallah, A., Harbison, C., Flowers, X. E., Coronas‐Samano, G., Maniatis, S., Daly, A. C., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02913-3 · Cited by 16
Kovacs, M., Trías, E., Varela, V., Ibarburu, S., Beckman, J. S., Moura, I. C., Hermine, O., King, P. H., Si, Y., Kwon, Y., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163880 · Cited by 14
Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia
Rossi, S., & Cozzolino, M. (2021) · Cells · doi:10.3390/cells10113005 · Cited by 15
Narlawar, R., Werry, E. L., Scarf, A. M., Hanani, R., Chua, S. W., King, V. A., Barron, M. L., Martins, R. N., Ittner, L. M., Rendina, L. M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01288 · Cited by 13
Self-citationImage Quantification for TSPO PET with a Novel Image-Derived Input Function Method
Fang, Y.-H. D., McConathy, J., Yacoubian, T. A., Zhang, Y., Kennedy, R., & Standaert, D. G. (2022) · Diagnostics · doi:10.3390/diagnostics12051161 · Cited by 12
Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials
Barp, A., Gerardi, F., Lizio, A., Sansone, V., & Lunetta, C. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1769067 · Cited by 13
Tsuruta, K., Shidara, T., Miyagishi, H., Nango, H., Nakatani, Y., Suzuki, N., Amano, T., Suzuki, T., & Kosuge, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813698 · Cited by 12
Wang, Y., & Patani, R. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1805734 · Cited by 10
Gangapuram, M., MAZZIO, E. A., Eyunni, S., Soliman, K. F. A., & Redda, K. K. (2014) · Archiv der Pharmazie · doi:10.1002/ardp.201300379 · Cited by 10
The Scientific and Therapeutic Rationale for Off‐Label Treatments in Amyotrophic Lateral Sclerosis
Bedlack, R., Li, X., Evangelista, B., Panzetta, M. E., Kwan, J. Y., Gittings, L. M., & Sattler, R. (2024) · Annals of Neurology · doi:10.1002/ana.27126 · Cited by 9
Ai, Y., Li, F. Y., Hou, Y., Li, X., Li, W., Qin, K., Suo, X., Lei, D., Shang, H., & Gong, Q. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad426 · Cited by 9
Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis
Amor, S., Nutma, E., Marzin, M. C., & Puentes, F. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13660 · Cited by 9
Willekens, S. M. A., Weehaeghe, D. V., Damme, P. V., & Laere, K. V. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3587-y · Cited by 9
Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases
Andrejew, R., Glaser, T., Oliveira‐Giacomelli, Á., Ribeiro, D. E., de Godoy, M. A., Granato, A. E. C., & Ulrich, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_14 · Cited by 10
18 kDa Translocator Protein TSPO Is a Mediator of Astrocyte Reactivity
Tournier, B. B., Bouteldja, F., Amossé, Q., Nicolaides, A., Azevedo, M. D., Tenenbaum, L., Garibotto, V., Ceyzériat, K., & Millet, P. (2023) · ACS Omega · doi:10.1021/acsomega.3c03368 · Cited by 9
Cocchi, M., Mondo, E., Romeo, M., & Traina, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063253 · Cited by 9
Does neuroinflammation sustain neurodegeneration in ALS?
Filippi, M., & Agosta, F. (2016) · Neurology · doi:10.1212/wnl.0000000000003441 · Cited by 7
Hong, Y., Shi, J., Feng, S., Huang, S., Yuan, Z., Liu, S., Zhang, X., Zhou, J., Jiang, T., Zhao, H.-D., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1552949 · Cited by 6
Glial Cells as Key Mediators in the Pathophysiology of Neurodegenerative Diseases
Bogus, K., Marchesi, N., Campagnoli, L. I. M., Pascale, A., & Pałasz, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020884 · Cited by 10
Bioactive Compound‐Fortified Nanocarriers in the Management of Neurodegenerative Disease: A Review
Singh, A., Maheshwari, S., Yadav, J. P., Kumar, R. K., Verma, A., Singh, S. K., & Prajapati, B. G. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402018 · Cited by 8
Vieira, I. F., Ory, D., Casteels, C., Lima, F. R. D. A., Laere, K. V., Bormans, G. M., & Koole, M. J. B. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0467-4 · Cited by 6
McCauley, K. S., Wilde, J. H., Bufalino, S. M., & Neumann, K. D. (2021) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2021.110032 · Cited by 6
Radiopharmaceuticals for PET imaging of neuroinflammation
Dupont, A.-C., Guilloteau, D., Kassiou, M., Ribeiro, M. J., Vercouillie, J., Katsifis, A. G., & Arlicot, N. (2016) · Médecine Nucléaire · doi:10.1016/j.mednuc.2016.01.001 · Cited by 6
Self-citationReversing binding sensitivity to A147T translocator protein
Vo, S. V., Banister, S. D., Freelander, I., Werry, E. L., Reekie, T. A., Ittner, L. M., & Kassiou, M. (2020) · RSC Medicinal Chemistry · doi:10.1039/c9md00580c · Cited by 6
Self-citationMensah, E. A., Faiyaz, A., Schifitto, G., & Uddin, M. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211059 · Cited by 5
Schiel, K. A. (2021) · BioEssays · doi:10.1002/bies.202100127 · Cited by 5
TSPO PET Imaging as a Biomarker of Neuroinflammation in Neurodegenerative Disorders
Werry, E. L., Bright, F., & Kassiou, M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_17 · Cited by 5
Self-citationNeuronal TDP-43 pathology drives astrocytic interferon response in a mouse model of ALS
An, J., Hendricks, N. E., Wheeler, J. M., Hincks, J. C., Benitez, J. A. R., Snyder, J. M., Kraemer, B. C., Liachko, N. F., & Elkon, K. B. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03658-2 · Cited by 4
PET Imaging of Translocator Protein Expression in Neurological Disorders
Brooks, D. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_30 · Cited by 4
Marini, C., Riondato, M., Dighero, E., Democrito, A., Losacco, S., Emionite, L., Nobbio, L., Patrizi, I. D., Camera, M., Ghersi, C., et al. (2025) · Biomolecules · doi:10.3390/biom15060799 · Cited by 3
Novel therapeutic approaches for motor neuron disease
Muzio, L., Ghirelli, A., Agosta, F., & Martino, G. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00027-2 · Cited by 3
La sclérose latérale amyotrophique : une maladie neurodégénérative emblématique
Viader, F. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.01.002 · Cited by 3
Swinnen, B., Laere, K. V., & Damme, P. V. (2016) · InTech eBooks · doi:10.5772/63545 · Cited by 2
Neuroinflammation: From Target Selection to Preclinical and Clinical Studies
Zinnhardt, B., Barca, C., Foray, C., Fricke, I. B., Viel, T., Winkeler, A., Windhorst, A. D., & Jacobs, A. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_17 · Cited by 3
Basic Concepts and Emergent Disease Mechanisms of Amyotrophic Lateral Sclerosis
Sirozh, O., Sáez-Mas, A., Lafarga, V., & Fernández-Capetillo, Ó. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00266-2 · Cited by 3
Thau‐Habermann, N., Gschwendtberger, T., Bodemer, C., & Petri, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319866 · Cited by 2
Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis
Maes, K. J. H., & Briedé, J. J. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150032 · Cited by 4
Molecular etiopathogenesis of neurodegenerative diseases
Divya, D., Thekkekkara, D., Sai, T. E., Ramakrishna, D., Manjula, S. N., & Goswami, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00002-7 · Cited by 2
PET Imaging of Translocator Protein Expression in Neurological Disorders
Brooks, D. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_22 · Cited by 2
Les nouvelles voies de recherche thérapeutique dans la sclérose latérale amyotrophique (SLA)
Danel-Brunaud, V., Moreau, C., Devos, D., & Defebvre, L. (2016) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2015.12.002 · Cited by 2
Turner, M. R., & Pagani, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_27 · Cited by 2
Sclérose latérale amyotrophique
Pradat, P., Corcia, P., & Meininger, V. (2016) · Cited by 3
Self-citationEvidence for a Growing Involvement of Glia in Amyotrophic Lateral Sclerosis
Radford, R. A. W., Vidal-Itriago, A., Scherer, N. M., Lee, A., Graeber, M. B., Chung, R. S., & Morsch, M. (2021) · Wiley eBooks · doi:10.1002/9781119745532.ch7 · Cited by 3
Metadata
- Authors
- Corcia, P., Tauber, C., Vercoullie, J., Arlicot, N., Prunier, C., Praline, J., Nicolas, G., Venel, Y., Hommet, C., Baulieu, J.-L., Cottier, J.-P., Roussel, C., Kassiou, M., Guilloteau, D., & Ribeiro, M.-J.
- Affiliations
- Université de Tours (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Corresponding author
- Corcia, Philippe
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-31
- Volume
- 7
- Issue
- 12
- Pages
- e52941
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3534121
- OpenAlex
- W2051387942
- Cited by
- 249
- References
- 42
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 8 · 2023: 13 · 2022: 19 · 2021: 28 · 2020: 28 · 2019: 20 · 2018: 13 · 2017: 21 · 2016: 23 · 2015: 23 · 2014: 25 · 2013: 6
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- FP7 Health (FP7/2007-2013)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, microglial activation, neuroinflammation, translocator protein (TSPO), [18F]DPA-714, positron emission tomography, distribution volume ratio, cerebral cortex, primary motor cortex, supplementary motor area, temporal cortex, biomarkers
- MeSH terms
- Aged, Amyotrophic Lateral Sclerosis, Brain, Female, Humans, Inflammation, Male, Middle Aged, Radionuclide Imaging, Microglia, Receptors, GABA, Molecular Imaging, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
